BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
-0.0050 (-7.69%)
At close: Feb 27, 2026
-40.00%
Market Cap 9.63M
Revenue (ttm) n/a
Net Income (ttm) -1.85M
Shares Out n/a
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,000
Average Volume 81,445
Open 0.0600
Previous Close 0.0650
Day's Range 0.0600 - 0.0600
52-Week Range 0.0400 - 0.1200
Beta 0.54
RSI 56.54
Earnings Date May 29, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.